Correlates of protection against SARS-CoV-2 infection and COVID-19 diseaseArticle Published on 2022-09-012022-11-15 Journal: Immunological reviews [Category] COVID19(2023년), SARS, 진단, [키워드] antibodies antibody binding binding antibody CD4 CD8 Cell cellular response coronavirus correlates correlation COVID-19 disease Efficacy epitope fc effector function highest Infection information measurement mucosal neutralization Predictive Protective responses SARS-COV-2 infection statistical T cell T cells the SARS-CoV-2 viral replication [DOI] 10.1111/imr.13091 PMC 바로가기
High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysisResearch article Published on 2022-09-012022-10-05 Journal: Journal of cardiothoracic and vascular anesthesia [Category] COVID19(2023년), SARS, 비임상, 임상, [키워드] Admission Analysis certainty of evidence Clinical efficacy coronavirus Corticosteroid Corticosteroids COVID-19 COVID-19 patients demonstrated Dexamethasone did not reduce dose evaluate Evidence group heterogeneity High-dose higher risk Hospital stay hyperglycemia ICU IMPROVE incidence Inconclusive infection rate intensive care low-dose corticosteroid low-dose corticosteroids measurement mechanical ventilation Meta-analysis Methylprednisolone mortality rate no significant difference objective observational study participant patients positive randomized clinical trial Randomized controlled trial Respiratory Support Result review SARS-CoV-2 SARS-CoV-2 PCR setting significant difference systematic review Trial trial sequential analysis [DOI] 10.1053/j.jvca.2022.05.011 [Article Type] Research article
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19COVID-19로 입원한 남성의 개선된 결과와 관련된 레닌-안지오텐신 시스템 경로 치료제Observational Study Published on 2022-09-012022-09-11 Journal: Critical Care Medicine [Category] 유전자 메커니즘, 임상, [키워드] ACE ACE inhibitor ACE inhibitors ACE-2 ACE2 gene acute COVID-19 acute COVID-19 illness acute respiratory syndrome acute respiratory syndrome coronavirus adjusted odds ratio Admission Analysis angiotensin Angiotensin II angiotensin receptor blocker Angiotensin receptor blockers Angiotensin-converting enzyme ARB ARBs baseline baseline characteristics cohort of patient Comorbidities component components contribute coronavirus COVID-19 COVID-19 illness d -dimer determine downregulate dysregulation Effect explain female females hospital Hospitalized hospitalized patient hospitalized patients Improved include inhibitor inhibitors Interaction less male measurement Mortality multicenter Observational cohort study organ support outcome outcomes Patient plasma polymerase chain polymerase chain reaction pro-inflammatory Prospective RAS recorded Renin renin-angiotensin system response severe acute respiratory syndrome Coronavirus Sex Sex-related differences significant effect significantly significantly higher System Therapeutics Treatment Vasopressor vasopressors Ventilation with COVID-19 X chromosome [DOI] 10.1097/CCM.0000000000005589 PMC 바로가기 [Article Type] Observational Study
Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCTRandomized Controlled Trial Published on 2022-09-012022-10-05 Journal: European journal of clinical nutrition [Category] 임상, [키워드] ALT AST attenuation baseline BMI Completer Contact Control control arm Controlled Effect effective Efficacy exacerbated Fatty liver groups hospital India Intensive Intervention intervention arm liver enzymes measurement NAFLD normalized obesity outcomes pandemic parameter parameters participant Patient patients with obesity Randomized RCT significant decrease significantly significantly higher steatosis stiffness therapy treat analysis Treatment outcome Trial was done weight were measured [DOI] 10.1038/s41430-022-01111-8 PMC 바로가기 [Article Type] Randomized Controlled Trial
Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in IcelandCOVID-19 환자의 염증성 바이오마커의 종단적 변화: 아이슬란드의 전국 연구Article Published on 2022-09-012022-09-11 Journal: Acta Anaesthesiologica Scandinavica [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] Admission admitted to ICU Ambulatory care Analysis Biomarker Biomarkers blood cell blood test blood tests C-reactive protein C-reactive protein (CRP Care Chain Reaction changes in Clinical outcome clinical outcomes collected correlated COVID-19 Critical Critical care CRP D-dimer death died disease severity elevated Evolution ferritin ferritin level ferritin levels groups hospital Hospitalization Hospitalized Iceland ICU individual Infection Inflammatory biomarker inflammatory biomarkers intensive care Laboratory laboratory markers Landspitali longitudinal longitudinal change longitudinal changes Lower lymphocyte Lymphocyte count measurement medical record neutrophil neutrophil counts occurred onset of symptoms outcome parameter Patient patients patients with COVID-19 plasma plasma CRP polymerase chain polymerase chain reaction positive predictor procalcitonin real-time polymerase chain reaction required RT-PCR SARS-CoV-2 scatterplot stratified sustained tested the mean Treatment university White blood cell [DOI] 10.1111/aas.14109 PMC 바로가기 [Article Type] Article
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation고염증을 동반한 COVID-19 폐렴의 치료를 위한 Clazakizumab의 무작위 이중 맹검 위약 대조 시험Clinical Trial Published on 2022-09-012022-09-12 Journal: Critical Care Medicine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 1:1 accompanied added Bayesian benefit board changes Clazakizumab Clinical outcome clinical status Controlled COVID-19 COVID-19 disease Critical cumulative double-blinded dropped enrolled Frequency greater High-dose hospitalized patient hyperinflammation ICU ICU admission inhibitor Inpatient interleukin-6 intubation Logistic low-dose measurement monitoring Odds ratio outcome Patient patients patients hospitalized Placebo placebo-controlled Poisson regression model Primary outcome Randomized receiving recommendations risk Safety seamless secondary secondary outcome severe COVID-19 disease significantly suggested survival Trial Ventilation ventilator-free survival were used with COVID-19 [DOI] 10.1097/CCM.0000000000005591 PMC 바로가기 [Article Type] Clinical Trial
Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analysesCovid-19에 대한 전통 중국 의약 치료 : 체계적인 검토 및 메타 분석의 개요Review Published on 2022-09-012022-08-31 Journal: Journal of integrative medicine [Category] meta-analysis, 임상, 치료법, [키워드] addition Analysis assessment can be used caused China Chinese Chinese traditional Chongqing clinical decision Clinical efficacy clinical outcomes clinical trial clinical trials Cochrane Library Combination control group conversion coronavirus disease Coronavirus disease 2019 COVID-19 data extraction Decision making defined development duration of symptoms Efficacy evaluate evaluated Evidence evidence of examined Factors Hospital stay improve clinical outcomes indicated Infrastructure integrative medicine intervention group lung measurement Medicine meta-analyses Meta-analysis Methodological quality moderate Mortality outcome outcome measure performed proliferation Randomized controlled trial Randomized controlled trials rapidly spreading disease review searched SinoMed Symptom systematic review systematic reviews TCM therapy Traditional Chinese medicine Treatment Version VIP was used Web of Science were used [DOI] 10.1016/j.joim.2022.06.006 PMC 바로가기 [Article Type] Review
Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsisArticle Published on 2022-08-302022-11-15 Journal: Critical Care [Category] 진단, [키워드] alteration assessment Biomarkers blood cell breadth Cell change Characteristics circulating classical contribute COVID-19 COVID-19 sepsis Critical care critical condition cytoplasmic death demonstrated distribution DNA drug extracellular trap granularity healthy healthy control heparin higher risk highlighting histone Histones in vitro in vivo Inflammatory involved key factor laboratory feature measurement Modification modulating monocyte Monocyte distribution width neutralization nuclear Pathologies Pathways Patient patients with COVID-19 procoagulant activity Prominent Protein Regulation released Sepsis sepsis patients severity significant increase subject thrombosis treated Treatment vacuolization Volume Whole blood whole blood sample [DOI] 10.1186/s13054-022-04138-2 PMC 바로가기
Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study3~16세 어린이의 SARS-CoV-2 혈청 유병률의 종단적 변화: 아우크스부르크 플러스 연구Article Published on 2022-08-112022-09-11 Journal: PLoS ONE [Category] SARS, 진단, 치료기술, [키워드] addition age antibody appear Asymptomatic asymptomatic infection asymptomatic infections baseline Blood Blot capillary blood capillary blood samples Child children Cohort collected Commission COVID-19 case COVID-19 vaccination detect diagnosed ELISA evaluate Filter Paper Follow-up Germany IgG IgG antibodies IgG antibody infected children Infection institution longitudinal measurement median number of infected oropharyngeal swab oropharyngeal swabs parent positive prevalence of COVID-19 Rapid test RBD reported Robert Koch SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 protein SARS-CoV-2 proteins SARS-CoV-2 seroprevalence SARS-CoV-2 spike protein School Sensitivity and specificity serological test Serological tests significantly Spike protein Standing study duration study period Swab tested Vaccine venous venous blood [DOI] 10.1371/journal.pone.0272874 PMC 바로가기 [Article Type] Article
Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW BiosensorSH-SAW 바이오센서를 이용한 예방접종 후 Anti-SARS-CoV-2 항체 수치 측정Article Published on 2022-08-042022-09-12 Journal: Biosensors [Category] SARS, 진단, [키워드] adenovirus vaccine adverse effect Anti-SARS-CoV-2 S antibody antibody concentration biosensor Blood Blood clots BNT chronic disease coated with Concentration COVID-19 pandemic cut-off diagnostic system fatigue first vaccination Health help in vitro increasingly induce Level Local measurement Moderna MONITOR mRNA vaccines myocarditis Pain pandemic Patient prevalence of COVID-19 Prevent Protein reduce SARS-CoV-2 SARS-CoV-2 spike protein second vaccination SH-SAW biosensor vaccination Vaccinations Vaccine was determined [DOI] 10.3390/bios12080599 PMC 바로가기 [Article Type] Article